共 50 条
- [21] Safety and Efficacy of Insulin Glargine 300 u/mL (Gla-300) Compared with Other Basal or Premixed Insulin Therapies in Patients with Type 2 Diabetes Mellitus (T2DM): A Network Meta-analysis (NMA)DIABETES, 2016, 65 : A566 - A566Freemantle, NickWang, HongweiThakur, DeepikaStella, PeterChanan, NehaKalra, ManikGuillermo, Jasso-Mosqueda Juan
- [22] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (gla-300) in Insulin-Naive Patients with Type 2 Diabetes (T2DM): Interim Analysis of the ATOS StudyDIABETES, 2020, 69Galstyan, Gagik R.Bhansali, AnilVargas-Uricoechea, HernandoTirosh, AmirSun, GuannanNaqvi, MubarakPilorget, ValerieCoudert, MathieuCherkasov, DmitryKhan, Niaz
- [23] Initiating Basal Insulin Supported Oral Therapy (BOT) with Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control in Patients (Pts) with Type 2 Diabetes (T2DM) without Increasing Hypoglycemia RiskDIABETES, 2018, 67Pfohl, MartinFritsche, AndreasAnderten, HelmutPegelow, KatrinPscherer, StefanSeufert, Jochen
- [24] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (Gla-300) in Older Adults (≥70 Years) with Type 2 Diabetes (T2DM): A Subgroup Analysis of the ATOS StudyDIABETES, 2021, 70Galstyan, Gagik R.Tirosh, AmirVargas-Uricoechea, HernandoMabunay, Maria Aileen N.Coudert, MathieuPilorget, ValerieKhan, Niaz
- [25] Older people with type 2 diabetes: glycaemic control and hypoglycaemia risk with new insulin glargine 300 U/ml (Gla-300)DIABETOLOGIA, 2015, 58 : S473 - S473Stella, P.Aroda, V.Charbonnel, B.Ritzel, R.Merino-Trigo, A.Grisoni, M. -L.Sinclair, A. J.Yale, J. -F.
- [26] The Use of Supportive Tools and Education Enables Self-Titration with Insulin Glargine 300 (Gla-300) or 100 U/mL (Gla-100) in People with Type 2 Diabetes (T2DM)-Results from TAKE CONTROL, INNOVATE, and AUTOMATIXDIABETES, 2018, 67Kvapil, MilanBonnemaire, MireilleGoyeau, HarmoniePapanas, NikolaosPopescu, LuizaSchultes, BerndSieber, JochenDuvnjak, Lea
- [27] Is hypoglycaemia a modifiable patient risk in type 2 diabetes: A pooled analysis of insulin glargine 300 U/mL (Gla-300) vs 100U/mL (Gla-100) trials?DIABETOLOGIA, 2015, 58 : S472 - S472Zhang, Q.Rosenstock, J.Gerrits, C.Liao, L.Chew, P.
- [28] Switching to Insulin Glargine 300 U/mL (Gla-300) after Failure of Advanced Insulin Therapy (IT) with Other Basal Insulins (BI) in Patients (Pts) with Type 2 Diabetes (T2DM) Improved Glycemic ControlDIABETES, 2018, 67Pscherer, StefanFritsche, AndreasAnderten, HelmutPegelow, KatrinSeufert, JochenPfohl, Martin
- [29] TAKE CONTROL: Efficacy and safety of patient-versus physician-managed titration of insulin Glargine 300 U/Ml (Gla-300) in patients with uncontrolled type 2 diabetesWIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 365 - 365Russel-Jones, DavidDauchy, ArnaudDelgado, EliasDimitriadis, GeorgeFrandsen, Hans AlbertPopescu, LuizaSchultes, BerndStrojek, KrzysztofHarreiter, JuergenBonnemaire, Mireille
- [30] Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL (Gla-300) vs. Glargine 100 U/mL (Gla-100) in Type 2 Diabetes (T2DM) in a Patient-Level Meta-analysis of 1-Yr Phase 3a EDITION StudiesDIABETES, 2015, 64 : A264 - A264Ritzel, RobertRoussel, RonanGiaccari, AndreaVora, Jiten P.Grisoni, Marie-LiseBrulle-Wohlhueter, ClaireGlezer, StanislavYki-Jazrvinen, Hannele